Piecing together the puzzle of progression and mortality in Parkinson's disease

被引：2

作者：

Marras, Connie ^{[1
,2
]}

Oakes, David ^{[3
]}

机构：

[1] Univ Toronto, Toronto Western Hosp, Movement Disorders Ctr, Toronto, ON M5T 2S8, Canada

[2] Edmond J Safra Program Parkinsons Res, Toronto, ON, Canada

[3] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY USA

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2012年 / 74卷 / 02期

关键词：

SELEGILINE;

D O I：

10.1111/j.1365-2125.2012.04315.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：264 / 266

页数：3

共 10 条

[1] Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease [J].

Churchyard, A ;

Mathias, CJ ;

Boonkongchuen, P ;

Lees, AJ .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (02) :228-234

[2] Selegiline and mortality in subjects with Parkinson's disease - A longitudinal community study [J].

Donnan, PT ;

Steinke, DT ;

Stubbings, C ;

Davey, PG ;

MacDonald, TM .

NEUROLOGY, 2000, 55 (12) :1785-1789

[3] Selegiline and Parkinson's disease - It's deja vu - again [J].

Langston, JW ;

Tanner, CM .

NEUROLOGY, 2000, 55 (12) :1770-1771

[4] Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease [J].

Lees, AJ .

BRITISH MEDICAL JOURNAL, 1995, 311 (7020) :1602-1607

[5] Predicting motor decline and disability in Parkinson disease - A systematic review [J].

Marras, C ;

Rochon, P ;

Lang, AE .

ARCHIVES OF NEUROLOGY, 2002, 59 (11) :1724-1728

[6] Effect of selegiline on mortality in patients with Parkinson's disease - A meta-analysis [J].

Olanow, CW ;

Myllyla, VV ;

Sotaniemi, KA ;

Larsen, JP ;

Palhagen, S ;

Przuntek, H ;

Heinonen, EH ;

Kilkku, O ;

Lammintausta, R ;

Maki-Ikola, O ;

Rinne, UK .

NEUROLOGY, 1998, 51 (03) :825-830

[7] Prognostic factors for the progression of Parkinson's disease: A systematic review [J].

Post, Bart ;

Merkus, Maruschka P. ;

De Haan, Rob J. ;

Speelman, Johannes D. .

MOVEMENT DISORDERS, 2007, 22 (13) :1839-1851

[8] Mortality in people taking selegiline: observational study [J].

Thorogood, M ;

Armstrong, B ;

Nichols, T ;

Hollowell, J .

BRITISH MEDICAL JOURNAL, 1998, 317 (7153) :252-254

[9] Progression of motor and nonmotor features of Parkinson's disease and their response to treatment [J].

Vu, Thuy C. ;

Nutt, John G. ;

Holford, Nicholas H. G. .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (02) :267-283

[10] Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease [J].

Vu, Thuy C. ;

Nutt, John G. ;

Holford, Nicholas H. G. .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (02) :284-295

← 1 →